Some of the drugs used to treat Crohn’s disease and ulcerative colitis increase the risk of malignant lymphoproliferative disorders including leukaemia and myeloma. Azathioprine and Mercaptopurine are immunosuppressive drugs used to maintain remission in inflammatory bowel diseases and in organ transplantation to reduce rejection. The increased cancer risk in organ transplant recipient has been known [...]
{ 0 comments }